Publication Name	World Journal of Clinical Oncology
Manuscript ID	16798
Country	Italy

Received	2015-01-29 08:10
Peer-Review Started	2015-02-02 09:04
To Make the First Decision	2015-04-27 15:33
Return for Revision	2015-04-30 08:17
Revised	2015-06-08 05:28
Second Decision	2015-08-27 11:53
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-09-08 14:54
Articles in Press	2015-09-08 14:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-24 10:46
Publish the Manuscript Online	2015-10-13 10:26

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	New findings on thymic epithelial tumors: Something is changing
Manuscript Source	Invited Manuscript
All Author List	Rossana Berardi, Francesca Morgese, Marina Chiara Garassino and Stefano Cascinu
Funding Agency and Grant Number
Corresponding Author	Rossana Berardi, MD, Department of Medical Oncology, Università Politecnica Marche, Via Conca 71, 60126 Ancona, Italy. r.berardi@univpm.it
Key Words	Thymic epithelial tumors; Thymoma; Thymic carcinoma; Targeted therapy; Programmed cell death-1
Core Tip	Thymic epithelial tumors (TETs) are uncommon neoplasms with a wide range of anatomical, clinical, histological and molecular malignant entities. To date the management of TETs within clinical practice is based on a multimodal therapeutic strategy including surgery, chemotherapy and radiotherapy with a multidisciplinary approach and prognostic evaluation is mainly based on Masaoka staging and World Health Organization classification. Targeted therapy will represent an important treatment option for TETs with an aggressive histology.
Publish Date	2015-10-13 10:26
Citation	Berardi R, Morgese F, Garassino MC, Cascinu S. New findings on thymic epithelial tumors: Something is changing. World J Clin Oncol 2015; 6(5): 96-98
URL	http://www.wjgnet.com/2218-4333/full/v6/i5/96.htm
DOI	http://dx.doi.org/10.5306/wjco.v6.i5.96

Full Article (PDF)	WJCO-6-96.pdf
Full Article (Word)	WJCO-6-96.doc
Manuscript File	16798-Review.docx
Answering Reviewers	16798-Answering reviewers.pdf
Audio Core Tip	16798-Audio core tip.MOV
Conflict-of-Interest Disclosure Form	16798-Conflict-of-interest statement.pdf
Copyright License Agreement	16798-Copyright assignment.pdf
Peer-review Report	16798-Peer-review(s).pdf
Scientific Misconduct Check	16798-Scientific misconduct check.pdf
Scientific Editor Work List	16798-Scientific editor work list.pdf